A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension
Rakugi, Hiromi, Shimizu, Kohei, Nishiyama, Yuya, Sano, Yuhei, Umeda, YuusukeLanguage:
english
Journal:
Blood Pressure
DOI:
10.1080/08037051.2017.1412797
Date:
December, 2017
File:
PDF, 1.25 MB
english, 2017